Severe superior mesenteric vein thrombosis after COVID ‐19 mRNA vaccination
Clinical Case Reports · 2023-05 · 11 (5)
DOI: 10.1002/ccr3.7354 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Case Reports, online erschienen am 18.05.2023. Verfasst von Takahiro Kubo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology Nara Medical University Kashihara Japan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Key Clinical Message Venous thrombosis is a rare occurrence following the administration of the COVID‐19 mRNA vaccine. The occurrence of superior mesenteric vein (SMV) is even more rare. SMV thrombosis should be considered as a differential diagnosis in patients who develop abdominal pain after COVID‐19 mRNA vaccination.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology Nara Medical University Kashihara Japan.
ORCID-Profile: Hideto Kawaratani
Zitieren
APA
Kubo, T., Kawaratani, H., & Yoshiji, H. (2023). Severe superior mesenteric vein thrombosis after COVID ‐19 mRNA vaccination. Clinical Case Reports, 11(5). https://doi.org/10.1002/ccr3.7354
Vancouver
Kubo T, Kawaratani H, Yoshiji H. Severe superior mesenteric vein thrombosis after COVID ‐19 mRNA vaccination. Clinical Case Reports. 2023;11(5). doi:10.1002/ccr3.7354
BibTeX
@article{Kubo2023,
author = {Kubo, Takahiro and Kawaratani, Hideto and Yoshiji, Hitoshi},
title = {Severe superior mesenteric vein thrombosis after COVID ‐19 mRNA vaccination},
journal = {Clinical Case Reports},
year = {2023},
volume = {11},
number = {5},
doi = {10.1002/ccr3.7354}
}
EUVIMED